Comparing dry needling and injection for jaw pain relief
Trigger Point Dry Needling vs Injection in Patients With Temporomandibular Disorders: a Randomized Placebo-controlled Trial
This study is testing whether dry needling or injection treatments can better relieve jaw pain for people with temporomandibular disorders.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 64 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Universidad Rey Juan Carlos Academic / other |
| Locations | 1 site (Alcorcón, Madrid) |
| Trial ID | NCT04726683 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of dry needling compared to injection treatments in alleviating pain and disability in patients suffering from temporomandibular disorders (TMD). Participants will receive either dry needling, injections, or placebo treatments to assess improvements in their condition over short, medium, and long-term periods. The study focuses on individuals with myofascial dysfunction of the jaw muscles, utilizing a randomized approach to determine the best intervention. The outcomes will help clarify the most effective treatment for TMD-related pain.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 60 with chronic jaw pain lasting more than six weeks due to myofascial temporomandibular dysfunction.
Not a fit: Patients with arthrogenous TMD or those who have had recent interventions on the masseter muscle may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide patients with a more effective treatment option for managing temporomandibular disorders.
How similar studies have performed: While there have been studies on dry needling and injections for pain management, this specific comparison in the context of TMD is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subjects aged between 18 and 60 years. 2. Pain of more than 6 weeks of evolution in the craniofacial region. 3. TMD with origin in the masticatory musculature according to the "DC-TMD" criteria. Exclusion Criteria: 1. Previous injection or dry needling intervention (3 months) on the masseter muscle. 2. Arthrogenous TMD. 3. History of trauma, infection in the temporomandibular joint in the last 6 months. 4. Coagulation disorders. 5. Pregnancy.
Where this trial is running
Alcorcón, Madrid
- Clínica Universitaria de la Universidad Rey Juan Carlos — Alcorcón, Madrid, Spain (Recruiting)
Study contacts
- Study coordinator: Josue Fernandez Carnero, PhD
- Email: josue.fernandez@urjc.es
- Phone: 914888949
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.